Anti-VEGF agents for the treatment of diabetic macular edema
<p> <br> </p> <p> <b>S.G. Sergushev<sup>1</sup>, E.N. Khomyakova<sup>2</sup></b> </p> <p> <b><sup>1</sup>A.I. Burnazyan Federal Medical Biological Center of the Federal Medical Biological Agency of Russia, M...
Saved in:
Main Authors: | S.G. Sergushev, E.N. Khomyakova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Prime-Media
2019-11-01
|
Series: | РМЖ "Клиническая офтальмология" |
Online Access: | http://clinopht.com/upload/iblock/8a8/8a83abd0639212d0a394f68ecebfe67f.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
by: Robert B. Garoon, et al.
Published: (2016-01-01) -
Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
by: Laura N. Distefano, et al.
Published: (2017-01-01) -
Application of deep learning algorithm for judicious use of anti-VEGF in diabetic macular edema
by: Anwesa Mondal, et al.
Published: (2025-02-01) -
Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
by: Filipe Mira, et al.
Published: (2017-01-01) -
Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
by: Ying Zhang, et al.
Published: (2022-01-01)